Predicting the outcomes of acute ischaemic stroke in atrial fi brillation: the role of baseline CHADS2, CHA2DS2-VASC and HAS-BLED score values
Explore this paper's citation graph
Summary
HAS-BLED was found to have an independent predictive value on the occurrence of sICH regardless of the treatment (thrombolysis or conservative therapy) and a trend toward statistical relation to the infl uence of the CHA2DS2-VASc values on the favourable outcome was registered.
- Type
- article
- Published
- 2013-12-01
- Cited by
- 8
- References
- 27
- OpenAlex
- https://openalex.org/W18034067
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:31054490
Keywords
Medicine, Atrial fibrillation, Stroke (engine), Internal medicine, Thrombolysis
References
- European Stroke Initiative Recommendations for Stroke Management – Update 2003
- A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice
- Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients
- Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation
- Underuse of oral anticoagulants in atrial fibrillation: a systematic review.
- Identifying Patients at High Risk for Stroke Despite Anticoagulation: A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort
- Classification of Cause of Death After Stroke in Clinical Research
- Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.
- Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
- Improving stroke risk stratification in atrial fibrillation.
- Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?
- Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation.
- Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
- Comparison between CHADS2 and CHA2DS2‐VASc score in a stroke cohort with atrial fibrillation
- Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the
- Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.
- Revised A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey
- Comparative assessment of the HAS-BLED score with other published bleeding risk scoring schemes, for intracranial haemorrhage risk in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study.
- Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.
Cited by
- The CHADS2 Components Are Associated with Stroke-Related In-hospital Mortality in Patients with Atrial Fibrillation.
- Predicting the Outcomes of Acute Ischemic Stroke with Rheumatic Heart Disease: The Values of CHADS2, CHA2DS2-VASc, and HAS-BLED Scores.
- Use of anticoagulation in non-rheumatic atrial fibrillation for stroke prevention
- Stroke Prevention in Atrial Fibrillation
- The CHA2DS2-VASC Score Predicts Mortality in Patients Undergoing Coronary Angiography
- Utilización de la anticoagulación en fibrilación auricular no reumática para profilaxis de accidentes cerebrovasculares Use of anticoagulation in non-rheumatic atrial fibrillation for stroke prevention
- Appendix A: Summary of evidence from surveillance
- Appendix A : Summary of evidence from surveillance 4-year surveillance ( 2017 ) – Atrial fibrillation : management ( 2014 ) NICE guideline
- Antitrombotična terapija kod pacijenata sa akutnim ishemijskim moždanim udarom i atrijalnom fibrilacijom Antithrombotic therapy in acute ischemic stroke patients with atrial fibrillation
Related papers
- Intra-Arterial Thrombolysis vs. Standard Treatment or Intravenous Thrombolysis in Adults with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
- Relationship between Post-Thrombolysis Blood Pressure and Outcome in Acute Ischemic Stroke Patients Undergoing Thrombolysis Therapy.
- Safety and Functional Outcome of Thrombolysis in Dissection-Related Ischemic Stroke: A Meta-Analysis of Individual Patient Data
- Impact of Admission Glucose and Diabetes on Recanalization and Outcome after Intra-Arterial Thrombolysis for Ischaemic Stroke
- Effectiveness and safety of ultrasound-enhanced thrombolysis for acute ischemic stroke
- Imaging-based thrombolysis trial in acute ischemic stroke-II (ITAIS-II).
- Very early neurological deterioration after thrombolysis (P11-5.021)
- Is stroke thrombolysis safe and efficacious in Hong Kong?
- Optimal blood pressure levels in different phases of peripheral thrombolysis period in acute ischemic stroke
- Impact of intravenous thrombolysis on functional outcome in patients with mild ischemic stroke without large vessel occlusion or rapidly improving symptoms